NASDAQ:EXPE charts & data provided by TradingView

Latest Insights on EXPE

Great Stuff 6-27-2019 Bitcoin’s Crypto Bubble, Thanks to Facebook Libra June 27, 2019 by Joseph Hargett Great Stuff Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]
ROBO ETF Is a Great Way to Invest in the Emerging Tech Revolution June 27, 2019 by Charles Mizrahi American Investor Today, Investment Opportunities, Technology Electricity changed the world forever. It would be very difficult for our modern society to exist without it. Nowadays, there is a new trend that’s already changing our way of living. Charles Mizrahi has a close eye on this profitable sector. (3-minute read)
Great Stuff 6-26-2019 Why Now is Not the Time to Buy Micron Stock June 26, 2019 by Joseph Hargett Great Stuff Chips are back, baby! Micron Technology Inc. (Nasdaq: MU) is parting the Red Sea, rallying more than 12% and leading semiconductor stocks to higher ground. Nvidia Corp. (Nasdaq: NVDA) and Advanced Micro Devices Inc. (Nasdaq: AMD) are both up about 5%. Applied Materials Inc. (Nasdaq: AMAT) is up nearly 4%. Even Qualcomm Inc. (Nasdaq: QCOM) […]
Big-Money Fed: 3 Reasons to Stay Bullish June 26, 2019 by John Ross American Investor Today, Economy, U.S. Economy Last Wednesday, the Federal Reserve made its announcement to support the market. John Ross talks about three reasons he believes the stocks are headed for an extended bull market. (4-minute read)
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This